What is he best known for?
The fields of study he is best known for:
- Gene
- Bacteria
- Antibiotics
His main research concerns Microbiology, Genetics, Mycobacterium tuberculosis, Staphylococcus aureus and Gene.
His Microbiology research integrates issues from Regulation of gene expression, Innate immune system and SCCmec.
The various areas that he examines in his Mycobacterium tuberculosis study include DNA profiling, Molecular epidemiology and Drug resistance.
As part of the same scientific family, Barry N. Kreiswirth usually focuses on Molecular epidemiology, concentrating on Typing and intersecting with Pulsed-field gel electrophoresis and Arginine catabolic mobile element.
His Staphylococcus aureus study incorporates themes from Immunology and Virulence.
His Tuberculosis research integrates issues from Transmission, Epidemiology, Disease and Surgery.
His most cited work include:
- Community-associated meticillin-resistant Staphylococcus aureus (1152 citations)
- The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage (1104 citations)
- Proposal for Standardization of Optimized Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Typing of Mycobacterium tuberculosis (1055 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Microbiology, Mycobacterium tuberculosis, Staphylococcus aureus, Tuberculosis and Klebsiella pneumoniae.
In his study, Pathogen is inextricably linked to Virulence, which falls within the broad field of Microbiology.
Barry N. Kreiswirth combines subjects such as DNA profiling, Genotyping, Restriction fragment length polymorphism, Genotype and Drug resistance with his study of Mycobacterium tuberculosis.
His work is dedicated to discovering how Tuberculosis, Molecular epidemiology are connected with Typing and other disciplines.
The various areas that Barry N. Kreiswirth examines in his Klebsiella pneumoniae study include Enterobacteriaceae and Multilocus sequence typing.
His Gene study improves the overall literature in Genetics.
He most often published in these fields:
- Microbiology (57.14%)
- Mycobacterium tuberculosis (25.48%)
- Staphylococcus aureus (22.97%)
What were the highlights of his more recent work (between 2018-2021)?
- Microbiology (57.14%)
- Klebsiella pneumoniae (20.08%)
- Antibiotics (11.20%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Microbiology, Klebsiella pneumoniae, Antibiotics, Avibactam and Plasmid.
Specifically, his work in Microbiology is concerned with the study of Meropenem.
His Klebsiella pneumoniae research incorporates elements of Internal medicine, Antibiotic resistance and Enterobacteriaceae.
His study with Antibiotic resistance involves better knowledge in Genetics.
Barry N. Kreiswirth has included themes like Efflux, Mycobacterium abscessus and Disease in his Antibiotics study.
His work carried out in the field of Plasmid brings together such families of science as Transposable element, Multilocus sequence typing, Polymerase chain reaction and Virulence.
Between 2018 and 2021, his most popular works were:
- Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli. (106 citations)
- Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent. (32 citations)
- Klebsiella pneumoniae ST307 with blaOXA-181, South Africa, 2014–2016 (29 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Bacteria
- Antibiotics
Barry N. Kreiswirth spends much of his time researching Microbiology, Klebsiella pneumoniae, Antibiotics, Avibactam and Enterobacteriaceae.
His research in Microbiology intersects with topics in Plasmid, Gene and Efflux.
His Klebsiella pneumoniae study combines topics in areas such as Prospective cohort study, Clade and Outbreak.
His Clade research is within the category of Genetics.
Barry N. Kreiswirth works mostly in the field of Antibiotics, limiting it down to topics relating to Drug resistance and, in certain cases, Vancomycin, Staphylococcus aureus, Antibacterial activity, Biofilm and Daptomycin.
His Enterobacteriaceae study combines topics from a wide range of disciplines, such as Serratia marcescens, Multilocus sequence typing and Pulsed-field gel electrophoresis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
